# ZBIO (Zenas BioPharma, Inc.) - SEC EDGAR Financial Statements

> Zenas BioPharma, Inc. reported $10.00M in revenue and a net loss of $541.8M for the fiscal year ended December 31, 2025 (up 100.0% year over year), with a -5264.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/ZBIO
- Markdown: https://convexityos.com/fundamentals/ZBIO.md
- SEC CIK: 0001953926
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:23 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001953926&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $10.00M | +100.0% YoY |
| Operating Income | FY 2025 | -$526.4M | -5264.0% margin |
| Net Income | FY 2025 | -$541.8M | -5418.1% net margin |
| Diluted EPS | FY 2025 | -$8.19 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$242.8M | -2428.3% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $585.3M | Total debt: $1.54M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $10.00M | $5.00M | $50.00M |
| Research & Development | $168.1M | $139.1M | $60.03M |
| Total Operating Expenses | $393.1M | $168.9M | $87.15M |
| **Operating Income** | -$383.1M | -$163.9M | -$37.15M |
| **EBITDA** | -$383.0M | -$163.8M | -$37.03M |
| Interest Income | $12.15M | $7.97M | -- |
| Interest Expense | $7.33M | -- | -- |
| Income Before Tax | -$377.8M | -$156.6M | -$36.82M |
| Income Tax Expense | -$79K | $429K | $301K |
| **Net Income** | -$377.7M | -$157.0M | -$37.12M |
| Basic EPS | -$8.44 | -$11.89 | -$24.25 |
| **Diluted EPS** | -$8.44 | -$11.89 | -$24.25 |
| Basic Shares Outstanding | 44.7M | 13.2M | 1.5M |
| Diluted Shares Outstanding | 44.7M | 13.2M | 1.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $10.00M | $1.00M | -- | $0 | $0 | $0 | $10.00M | -- |
| Research & Development | $58.47M | $62.91M | $60.44M | $55.72M | $34.40M | $43.03M | $34.91M | $49.16M |
| Total Operating Expenses | $113.4M | $108.7M | $77.35M | $238.0M | $52.58M | $55.16M | $47.33M | $60.62M |
| **Operating Income** | -$103.4M | -$107.7M | -$77.35M | -$238.0M | -$52.58M | -$55.16M | -$37.33M | -$55.62M |
| **EBITDA** | -$103.4M | -$107.7M | -$77.34M | -$238.0M | -$52.57M | -$55.15M | -$37.31M | -$55.59M |
| Interest Income | $5.79M | $6.60M | $3.02M | $3.25M | $2.77M | $2.74M | $3.39M | -- |
| Interest Expense | $2.06M | $1.72M | $368K | -- | -- | -- | -- | -- |
| Income Before Tax | -$108.9M | -$111.3M | -$80.99M | -$240.3M | -$51.50M | -$52.20M | -$33.78M | -$52.17M |
| Income Tax Expense | $49K | $114K | -- | $106K | $0 | $20K | -$205K | -- |
| **Net Income** | -$108.9M | -$111.5M | -$80.99M | -$240.4M | -$51.50M | -$52.22M | -$33.57M | -$52.60M |
| Basic EPS | -$1.65 | -$1.77 | -$1.46 | -- | -$1.22 | -$1.25 | -$0.80 | -- |
| **Diluted EPS** | -$1.65 | -$1.77 | -$1.46 | -- | -$1.22 | -$1.25 | -$0.80 | -- |
| Basic Shares Outstanding | 66.1M | 63.1M | 55.6M | -- | 42.2M | 41.9M | 41.8M | -- |
| Diluted Shares Outstanding | 66.1M | 63.1M | 55.6M | -- | 42.2M | 41.9M | 41.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $110.6M | $319.7M | $56.86M |
| Short-Term Investments | $232.6M | $31.02M | -- |
| **Cash & Short-Term Investments** | $360.5M | $350.8M | $56.86M |
| **Total Current Assets** | $351.2M | $355.9M | $59.80M |
| Property, Plant & Equipment, Net | $34K | $185K | $193K |
| Long-Term Investments | $17.27M | -- | -- |
| Other Non-Current Assets | $13.81M | $12.86M | $7.28M |
| **Total Non-Current Assets** | $32.47M | $14.04M | $8.38M |
| **Total Assets** | $383.6M | $370.0M | $68.18M |
| Accounts Payable | $7.11M | $17.14M | $5.40M |
| **Total Current Liabilities** | $62.65M | $57.29M | $23.26M |
| Long-Term Debt | $78.64M | -- | -- |
| **Total Non-Current Liabilities** | $78.85M | $218K | $20.56M |
| **Total Liabilities** | $141.5M | $57.51M | $43.81M |
| **Total Debt (incl. Leases)** | $79.96M | $1.00M | $813K |
| Common Stock | $5.0K | $4.0K | -- |
| Retained Earnings | -$765.1M | -$387.4M | -$230.4M |
| Accumulated Other Comp. Income | -$64K | $194K | $37K |
| **Total Stockholders' Equity** | $242.1M | $312.5M | -$225.7M |
| Total Equity | $242.1M | $312.5M | -$225.7M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $177.8M | $196.6M | $500.2M | $110.6M | $115.6M | $44.01M | $196.6M | $319.7M |
| Short-Term Investments | $407.5M | $446.5M | $217.0M | $232.6M | $175.3M | $229.3M | $115.8M | $31.02M |
| **Cash & Short-Term Investments** | $647.1M | $673.9M | $718.5M | $360.5M | $301.6M | $274.9M | $314.2M | $350.8M |
| **Total Current Assets** | $603.4M | $653.8M | $730.2M | $351.2M | $296.6M | $278.6M | $317.8M | $355.9M |
| Property, Plant & Equipment, Net | $19K | $23K | $28K | $34K | $50K | $61K | $72K | $185K |
| Long-Term Investments | $61.77M | $30.76M | $1.34M | $17.27M | $10.72M | $1.61M | $1.83M | -- |
| Other Non-Current Assets | $8.39M | $16.29M | $15.06M | $13.81M | $13.80M | $11.80M | $12.85M | $12.86M |
| **Total Non-Current Assets** | $71.77M | $47.90M | $17.52M | $32.47M | $25.38M | $14.48M | $15.96M | $14.04M |
| **Total Assets** | $675.2M | $701.7M | $747.7M | $383.6M | $322.0M | $293.1M | $333.8M | $370.0M |
| Accounts Payable | $7.06M | $7.59M | $8.94M | $7.11M | $6.44M | $7.93M | $20.02M | $17.14M |
| Deferred Revenue (Current) | $2.03M | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $64.04M | $65.82M | $61.16M | $62.65M | $52.42M | $53.24M | $49.13M | $57.29M |
| Long-Term Debt | -- | -- | -- | $78.64M | $72.99M | -- | -- | -- |
| **Total Non-Current Liabilities** | $398.9M | $388.8M | $350.7M | $78.85M | $73.17M | $215K | $317K | $218K |
| **Total Liabilities** | $462.9M | $454.6M | $411.9M | $141.5M | $125.6M | $53.46M | $49.45M | $57.51M |
| **Total Debt (incl. Leases)** | $1.54M | $845K | $1.11M | $79.96M | $73.79M | $1.01M | $1.23M | $1.00M |
| Common Stock | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K |
| Retained Earnings | -$1.07B | -$957.6M | -$846.1M | -$765.1M | -$524.7M | -$473.2M | -$421.0M | -$387.4M |
| Accumulated Other Comp. Income | -$1.26M | -$1.14M | -$377K | -$64K | -$69K | -$94K | $141K | $194K |
| **Total Stockholders' Equity** | $212.3M | $247.1M | $335.8M | $242.1M | $196.4M | $239.6M | $284.3M | $312.5M |
| Total Equity | $212.3M | $247.1M | $335.8M | $242.1M | $196.4M | $239.6M | $284.3M | $312.5M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$377.7M | -$157.0M | -$37.12M |
| Depreciation & Amortization | $56K | $137K | $113K |
| Stock-Based Compensation | $26.35M | $10.82M | $3.50M |
| Change in Payables | -$10.04M | $11.74M | -$418K |
| **Operating Cash Flow** | -$172.3M | -$119.7M | -$30.53M |
| Capital Expenditure | -$18K | -$131K | -$17K |
| **Free Cash Flow** | -$172.4M | -$119.8M | -$30.55M |
| Purchases of Investments | -$417.8M | -$36.42M | -- |
| Sales & Maturities of Investments | $200.9M | $6.00M | -- |
| **Investing Cash Flow** | -$251.9M | -$30.55M | -$17K |
| **Financing Cash Flow** | $215.3M | $413.0M | $20.12M |
| **Net Change in Cash** | -$209.2M | $262.9M | -$10.35M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$108.9M | -$111.5M | -$80.99M | -$240.4M | -$51.50M | -$52.22M | -$33.57M | -$52.60M |
| Depreciation & Amortization | $4.0K | $4.0K | $6.0K | $10K | $11K | $12K | $23K | $33K |
| Stock-Based Compensation | $17.28M | $8.62M | $9.20M | $7.58M | $7.34M | $6.04M | $5.39M | $5.50M |
| Change in Payables | -$514K | -$1.33M | $1.79M | $1.12M | -$1.95M | -$12.09M | $2.88M | $5.42M |
| **Operating Cash Flow** | -$57.98M | -$57.24M | -$75.20M | -$52.41M | -$41.12M | -$41.74M | -$37.05M | -$38.55M |
| Capital Expenditure | -$1.0K | $0 | -$2.0K | $0 | $0 | $0 | -$18K | -$74K |
| **Free Cash Flow** | -$57.98M | -$57.24M | -$75.20M | -$52.41M | -$41.12M | -$41.74M | -$37.07M | -$38.63M |
| Purchases of Investments | -$137.5M | -$331.8M | -$76.52M | -$132.9M | -$59.20M | -$126.6M | -$99.11M | -- |
| Sales & Maturities of Investments | $145.8M | $74.11M | $108.1M | $69.53M | $104.2M | $14.26M | $12.86M | -- |
| **Investing Cash Flow** | -$19.21M | -$287.7M | $31.61M | -$93.36M | $40.04M | -$112.3M | -$86.27M | -$3.73M |
| **Financing Cash Flow** | $57.21M | $42.06M | $433.5M | $140.8M | $72.62M | $1.72M | $99K | $1.85M |
| **Net Change in Cash** | -$18.80M | -$303.6M | $389.6M | -$4.92M | $71.56M | -$152.5M | -$123.3M | -$40.30M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Operating Margin** | -3830.6% | -3277.8% | -74.3% |
| **Net Profit Margin** | -3777.4% | -3139.8% | -74.2% |
| Return on Equity (ROE) | -156.0% | -50.2% | -- |
| Return on Assets (ROA) | -98.5% | -42.4% | -54.4% |
| Current Ratio | 5.61x | 6.21x | 2.57x |
| Quick Ratio | 5.75x | 6.12x | 2.44x |
| Debt to Equity | 0.33x | 0.00x | -- |
| **Revenue Growth (YoY)** | +100.0% | -90.0% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -3830.6% | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -- | -- | -3777.4% | -- | -- | -- | -- |
| Return on Equity (ROE) | -255.2% | -196.0% | -126.6% | -156.0% | -96.7% | -73.9% | -57.2% | -50.2% |
| Return on Assets (ROA) | -80.2% | -69.0% | -56.9% | -98.5% | -59.0% | -60.4% | -48.8% | -42.4% |
| Current Ratio | 9.42x | 9.93x | 11.94x | 5.61x | 5.66x | 5.23x | 6.47x | 6.21x |
| Quick Ratio | 10.10x | 10.24x | 11.75x | 5.75x | 5.75x | 5.16x | 6.40x | 6.12x |
| Debt to Equity | 0.01x | 0.00x | 0.00x | 0.33x | 0.38x | 0.00x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
